|
DDX1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.72528658026749E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.66910929522146E-12 |
| Normal-vs-Stage2 |
3.5443000000468E-06 |
| Normal-vs-Stage3 |
5.90050000000009E-05 |
| Normal-vs-Stage4 |
5.76080000369572E-08 |
| Stage1-vs-Stage2 |
7.742400E-01 |
| Stage1-vs-Stage3 |
3.040000E-01 |
| Stage1-vs-Stage4 |
7.645600E-01 |
| Stage2-vs-Stage3 |
5.723200E-01 |
| Stage2-vs-Stage4 |
5.571800E-01 |
| Stage3-vs-Stage4 |
3.336600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.63824509513688E-12 |
| Normal-vs-AfricanAmerican |
9.03369999916137E-08 |
| Normal-vs-Asian |
1.386390E-01 |
| Caucasian-vs-AfricanAmerican |
1.620160E-01 |
| Caucasian-vs-Asian |
4.737800E-01 |
| AfricanAmerican-vs-Asian |
8.284200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62503344114384E-12 |
| Normal-vs-Female |
2.573000E-04 |
| Male-vs-Female |
1.045250E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.55130000354131E-09 |
| Normal-vs-Extreme_Weight |
1.62625468647093E-12 |
| Normal-vs-Obese |
1.60499999957153E-08 |
| Normal-vs-Extreme_Obese |
6.176000E-03 |
| Normal_Weight-vs-Extreme_Weight |
4.846800E-01 |
| Normal_Weight-vs-Obese |
3.440600E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.037200E-01 |
| Extreme_Weight-vs-Obese |
5.132400E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.785400E-01 |
| Obese-vs-Extreme_Obese |
6.661800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.736210E-02 |
| Normal-vs-Age(41-60Yrs) |
1.11969988836336E-10 |
| Normal-vs-Age(61-80Yrs) |
1.62647673107585E-12 |
| Normal-vs-Age(81-100Yrs) |
7.249400E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.940400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.924100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.571350E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.600200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.478800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.855800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.65634173043827E-12 |
| Normal-VS-Type2 PRCC |
1.04169994852299E-09 |
| Normal-VS-KIRP CIMP |
7.542500E-02 |
| Normal-VS-Unclassified PRCC |
1.73377000000086E-05 |
| Type1 PRCC-VS-Type2 PRCC |
8.809400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.296770E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.562200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.365800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.220000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.751000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.79089965079982E-10 |
| Normal-vs-N1 |
1.252400E-02 |
| Normal-vs-N2 |
4.771500E-04 |
| N0-vs-N1 |
2.551500E-02 |
| N0-vs-N2 |
8.929400E-01 |
| N1-vs-N2 |
2.859200E-01 |
|
|
